Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$75.38 USD

75.38
1,288,503

+0.28 (0.37%)

Updated Apr 19, 2024 04:00 PM ET

After-Market: $75.37 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth

by Zacks Equity Research

Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.

Hologic (HOLX) Increases Despite Market Slip: Here's What You Need to Know

by Zacks Equity Research

Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.

Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail

by Zacks Equity Research

Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.

Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know

by Zacks Equity Research

Hologic (HOLX) concluded the recent trading session at $77.38, signifying a -0.77% move from its prior day's close.

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Hologic (HOLX) Stock Moves -0.05%: What You Should Know

by Zacks Equity Research

Hologic (HOLX) reachead $76.08 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

by Zacks Equity Research

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hologic (HOLX) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.

GE HealthCare (GEHC) Uses AI Solution to Boost Medical Imaging

by Zacks Equity Research

GE HealthCare's (GEHC) SonoSAMTrack demonstrates its pliability and applicability in ultrasound image segmentation by using NVIDIA's technology.

QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness

by Zacks Equity Research

QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.

Hologic (HOLX) Rises But Trails Market: What Investors Should Know

by Zacks Equity Research

Hologic (HOLX) concluded the recent trading session at $76.35, signifying a +0.58% move from its prior day's close.

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Hologic (HOLX) Stock Declines While Market Improves: Some Information for Investors

by Zacks Equity Research

In the latest trading session, Hologic (HOLX) closed at $75.64, marking a -0.9% move from the previous day.

Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?

by Zacks Equity Research

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hologic's (HOLX) BCI Genomic Test Study Outcome Favorable

by Zacks Equity Research

Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.

Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

by Zacks Equity Research

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

HOLX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HOLX vs. EW: Which Stock Is the Better Value Option?

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

HOLX vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

HOLX vs. SONVY: Which Stock Is the Better Value Option?